Evaluation of Tissue Glue on PICC and Midline Catheters Insertion Sites
- Conditions
- Adult Patients With Mid-term or Long-term Venous Access
- Registration Number
- NCT04900740
- Lead Sponsor
- University Hospital Ostrava
- Brief Summary
The study will evaluate a new type of cyanoacrylate tissue glue Secure PortIV on the insertion site of the PICC (Peripherally inserted central catheter) or Midline catheters. Fixation of the catheter with the tissue glue should prevent incidents of mechanical and infective phlebitis as well as external migrations of the catheters.
- Detailed Description
In the study, 125 subjects will receive the new tissue glue Secure PortIV and 125 subjects will be provided standard care. The tissue glue will be applied immediately after insertion. Evaluation and re-evaluation of the site will be done on the first and seventh day after insertion using VIP and CLISA (Central-Line Insertion Site Assessment) scale and on the seventh day with taking a swab from the insertion site; the external length will be measured on the first and the seventh day, in order to observe the migration or not.
The goal of the study is to evaluate the benefits of the cyanoacrylate tissue glue Secure PortIV in the prevention of mechanical and infective phlebitis and external migration of the catheter.
Recruitment & Eligibility
- Status
- RECRUITING
- Sex
- All
- Target Recruitment
- 250
- 18 years of age
- need of long-term venous access
- consent with participation in the study
- pediatric population
- not signing the informed consent form
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Primary Outcome Measures
Name Time Method The incidence of mechanical and infective phlebitis Up to 6 months The incidence of mechanical and infective phlebitis will be measured in the group with the cyanoacrylate tissue glue in comparison with the standard treatment
- Secondary Outcome Measures
Name Time Method The incidence of external migration of the catheter Up to 6 months The incidence of external migration of the catheter will be measured in the group with the cyanoacrylate tissue glue in comparison with the standard treatment
Trial Locations
- Locations (1)
University Hospital Ostrava
🇨🇿Ostrava, Moravian-Silesian Region, Czechia
University Hospital Ostrava🇨🇿Ostrava, Moravian-Silesian Region, CzechiaJiří HynčicaContact0042059737jiri.hyncica@fno.czIveta Constantine, Bc., MSc.Principal InvestigatorAndrea Polanská, PhDr., MBASub InvestigatorMagda Michalíková, DiSSub InvestigatorZuzana FigurováSub Investigator